NYSE:NHINational Health Investors Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding National Health Investors Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $65.69 -0.56 (-0.85 %) (As of 08/12/2020 04:00 PM ET) Add Compare Share Today's Range$65.28Now: $65.69▼$69.8150-Day Range$55.93MA: $60.34▼$66.2552-Week Range$31.37Now: $65.69▼$91.12Volume385,600 shsAverage Volume370,706 shsMarket Capitalization$2.93 billionP/E Ratio15.60Dividend Yield6.71%Beta0.83 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.Read More Beat the Market (BTM) Rank™ 1.0 Analyst's Opinion Consensus RatingNational Health Investors has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 5 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $66.83, National Health Investors has a potential upside of 1.7% from its current price of $65.69.Amount of Analyst CoverageNational Health Investors has only been the subject of 4 research reports in the past 90 days. Previous Next 2.1 Community Rank Outperform VotesNational Health Investors has received 324 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNational Health Investors has received 434 “underperform” votes. (Add your “underperform” vote.)Community SentimentNational Health Investors has received 57.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about National Health Investors and other stocks. Vote “Outperform” if you believe NHI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NHI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 3.3 Dividend Strength Dividend LeadershipNational Health Investors is a leading dividend payer. It pays a dividend yield of 6.71%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNational Health Investors has been increasing its dividend for 10 years.Dividend CoverageThe dividend payout ratio of National Health Investors is 80.18%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, National Health Investors will have a dividend payout ratio of 79.46% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Health Investors insiders have bought more of their company's stock than they have sold. Specifically, they have bought $20,553.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 5.74% of the stock of National Health Investors is held by insiders.Percentage Held by Institutions68.92% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for National Health Investors are expected to decrease by -1.07% in the coming year, from $5.61 to $5.55 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Health Investors is 15.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 17.40.Price to Earnings Ratio vs. SectorThe P/E ratio of National Health Investors is 15.60, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.65.Price to Book Value per Share RatioNational Health Investors has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.0Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.34 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance Current SymbolNYSE:NHI Previous Symbol CUSIP63633D10 CIK877860 Webwww.nhireit.com Phone615-890-9100Debt Debt-to-Equity Ratio1.03 Current Ratio12.05 Quick Ratio12.05Price-To-Earnings Trailing P/E Ratio15.60 Forward P/E Ratio11.71 P/E GrowthN/A Sales & Book Value Annual Sales$318.08 million Price / Sales9.22 Cash Flow$5.52 per share Price / Cash Flow11.89 Book Value$34.08 per share Price / Book1.93Profitability EPS (Most Recent Fiscal Year)$5.50 Net Income$160.46 million Net Margins57.16% Return on Equity12.62% Return on Assets6.08%Miscellaneous Employees16 Outstanding Shares44,650,000Market Cap$2.93 billion Next Earnings Date11/5/2020 (Estimated) OptionableOptionable $65.69 -0.56 (-0.85 %) (As of 08/12/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive NHI News and Ratings via Email Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter. National Health Investors (NYSE:NHI) Frequently Asked Questions How has National Health Investors' stock price been impacted by COVID-19? National Health Investors' stock was trading at $70.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NHI shares have decreased by 7.3% and is now trading at $65.69. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of National Health Investors? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for National Health Investors. When is National Health Investors' next earnings date? National Health Investors is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for National Health Investors. How were National Health Investors' earnings last quarter? National Health Investors Inc (NYSE:NHI) posted its earnings results on Monday, August, 10th. The real estate investment trust reported $0.99 earnings per share for the quarter, missing analysts' consensus estimates of $1.43 by $0.44. The real estate investment trust earned $84.17 million during the quarter, compared to analyst estimates of $83.11 million. National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. National Health Investors's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.36 earnings per share. View National Health Investors' earnings history. How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors? National Health Investors declared a quarterly dividend on Monday, June 15th. Stockholders of record on Tuesday, June 30th will be given a dividend of $1.102 per share on Friday, August 7th. This represents a $4.41 annualized dividend and a yield of 6.71%. The ex-dividend date of this dividend is Monday, June 29th. View National Health Investors' dividend history. What price target have analysts set for NHI? 7 analysts have issued 12 month target prices for National Health Investors' stock. Their forecasts range from $40.00 to $94.00. On average, they expect National Health Investors' share price to reach $66.83 in the next year. This suggests a possible upside of 1.7% from the stock's current price. View analysts' price targets for National Health Investors. Has National Health Investors been receiving favorable news coverage? News coverage about NHI stock has trended extremely negative on Thursday, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. National Health Investors earned a news impact score of -4.1 on InfoTrie's scale. They also gave headlines about the real estate investment trust a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about National Health Investors. Are investors shorting National Health Investors? National Health Investors saw a decrease in short interest in May. As of May 15th, there was short interest totaling 1,200,000 shares, a decrease of 20.5% from the April 30th total of 1,510,000 shares. Based on an average trading volume of 492,100 shares, the short-interest ratio is currently 2.4 days. Currently, 2.9% of the company's shares are short sold. View National Health Investors' Short Interest. Who are some of National Health Investors' key competitors? Some companies that are related to National Health Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Ventas (VTR), HCP (HCP), Extra Space Storage (EXR), Medical Properties Trust (MPW), Host Hotels and Resorts (HST), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), Healthcare Realty Trust (HR), Rayonier (RYN) and Sabra Health Care REIT (SBRA). View all competitors. What other stocks do shareholders of National Health Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Cisco Systems (CSCO), Verizon Communications (VZ), ANNALY CAP MGMT/SH (NLY), Energy Transfer LP Unit (ET), JPMorgan Chase & Co. (JPM), Intel (INTC), Broadcom (AVGO) and Enterprise Products Partners (EPD). Who are National Health Investors' key executives? National Health Investors' management team includes the following people: Mr. D. Eric Mendelsohn, Pres & CEO (Age 57)Mr. John L. Spaid, Exec. VP of Fin. (Age 59)Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 38)Mr. Roger R. Hopkins, Chief Accounting Officer (Age 57)Ms. Colleen Schaller, Director, Investor Relations What is National Health Investors' stock symbol? National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI." Who are National Health Investors' major shareholders? National Health Investors' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (2.38%), Hamlin Capital Management LLC (1.93%), Goldman Sachs Group Inc. (1.71%), Principal Financial Group Inc. (1.11%), GW&K Investment Management LLC (0.92%) and LSV Asset Management (0.78%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Kristin Sallee Gaines, Robert A Mccabe Jr, Robert A Mccabe, Jr, Robert G Adams, Robert T Webb and W Andrew Adams. View institutional ownership trends for National Health Investors. Which major investors are selling National Health Investors stock? NHI stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., First Trust Advisors LP, Principal Financial Group Inc., Bessemer Group Inc., UBS Group AG, Jaguar Listed Property LLC, WINTON GROUP Ltd, and GW&K Investment Management LLC. Company insiders that have sold National Health Investors company stock in the last year include D Eric Mendelsohn, James R Jobe, and Kevin Carlton Pascoe. View insider buying and selling activity for National Health Investors. Which major investors are buying National Health Investors stock? NHI stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Hamlin Capital Management LLC, Bank of New York Mellon Corp, LSV Asset Management, Healthcare of Ontario Pension Plan Trust Fund, Prudential Financial Inc., Mesirow Financial Investment Management Equity Management, and Barclays PLC. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams. View insider buying and selling activity for National Health Investors. How do I buy shares of National Health Investors? Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is National Health Investors' stock price today? One share of NHI stock can currently be purchased for approximately $65.69. How big of a company is National Health Investors? National Health Investors has a market capitalization of $2.93 billion and generates $318.08 million in revenue each year. The real estate investment trust earns $160.46 million in net income (profit) each year or $5.50 on an earnings per share basis. National Health Investors employs 16 workers across the globe. What is National Health Investors' official website? The official website for National Health Investors is www.nhireit.com. How can I contact National Health Investors? National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected] This page was last updated on 8/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
